Related Experiment Videos
Pacemaker-mediated tachycardias: a rapid bedside technique for induction and observation
The American Journal of Cardiology
|August 1, 1983
Summary
Ventriculoatrial (VA) conduction can cause pacemaker-mediated tachycardia in patients with DDD pacemakers. A simple bedside test can detect VA conduction, allowing for timely management to prevent tachycardia.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- DDD pacemakers maintain atrioventricular synchrony but can create ventriculoatrial (VA) conduction.
- VA conduction in DDD pacemaker patients can lead to pacemaker-mediated tachycardia (PMT).
Purpose of the Study:
- To evaluate a simple bedside technique for detecting VA conduction after DDD pacemaker implantation.
- To assess the incidence and implications of VA conduction and PMT in DDD pacemaker patients.
Main Methods:
- A bedside technique was used to detect VA conduction in 31 patients post-DDD pacemaker implantation.
- Ambulatory monitoring (Holter) and external pacemaker stimulation were employed to detect PMT.
- Atrial refractory period programming was used to manage or induce PMT.
Main Results:
- All 17 patients with detectable VA conduction experienced PMT when the atrial refractory period was less than VA conduction time.
- PMT was not inducible when the atrial refractory period was ≥ VA conduction time + 50 ms.
- VA conduction became undetectable in 9 patients later; 6 required antiarrhythmic therapy or developed heart failure.
Conclusions:
- VA conduction is a significant factor in DDD pacemaker patients, potentially leading to PMT.
- A simple bedside evaluation can readily assess VA conduction.
- Management of the atrial refractory period is crucial for preventing PMT in the presence of VA conduction.